Cargando…
The impact of rituximab infusion protocol on the long‐term outcome in anti‐MuSK myasthenia gravis
OBJECTIVE: To evaluate whether the clinical benefit and relapse rates in anti‐muscle‐specific kinase (MuSK) myasthenia gravis (MG) differ depending on the protocol of rituximab followed. METHODS: This retrospective multicentre study in patients with MuSK MG compared three rituximab protocols in term...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989782/ https://www.ncbi.nlm.nih.gov/pubmed/29928654 http://dx.doi.org/10.1002/acn3.564 |